Diffuse cystic lung disease: Part I

Nishant Gupta, Robert Vassallo, Kathryn A. Wikenheiser-Brokamp, Francis X. McCormack

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Abstract

The diffuse cystic lung diseases (DCLDs) are a group of pathophysiologically heterogenous processes that are characterized by the presence of multiple spherical or irregularly shaped, thin-walled, air-filled spaces within the pulmonary parenchyma. Although the mechanisms of cyst formation remain incompletely defined for all DCLDs, in most cases lung remodeling associated with inflammatory or infiltrative processes results in displacement, destruction, or replacement of alveolar septa, distal airways, and small vessels within the secondary lobules of the lung. The DCLDs can be broadly classified according to underlying etiology as those caused by low-grade or high-grade metastasizing neoplasms, polyclonal or monoclonal lymphoproliferative disorders, infections, interstitial lung diseases, smoking, and congenital or developmental defects. In the first of a two-part series, we present an overview of the cystic lung diseases caused by neoplasms, infections, smoking-related diseases, and interstitial lung diseases, with a focus on lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis.

Original languageEnglish (US)
Pages (from-to)1354-1366
Number of pages13
JournalAmerican journal of respiratory and critical care medicine
Volume191
Issue number12
DOIs
StatePublished - Jun 15 2015

Keywords

  • High-resolution computed tomography
  • Lung cysts
  • Lymphangioleiomyomatosis
  • Pulmonary Langerhans cell histiocytosis
  • Tuberous sclerosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Fingerprint Dive into the research topics of 'Diffuse cystic lung disease: Part I'. Together they form a unique fingerprint.

Cite this